A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS)
Advanced Biomedical Research · 2025-01 · 14 (1)
DOI: 10.4103/abr.abr_262_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biomedical Research, 2025-01. Verfasst von Nirmal Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, ABVIMS and Dr. RML Hospital, New Delhi, India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
The measurement of androgens (testosterone and dehydroepiandrosterone sulfate (DHEAS)) remains standard for the evaluation of polycystic ovarian syndrome (PCOS) women. However, other early novel androgen markers, 5 alpha-dihydrotestosterone (DHT) and 11-ketotestosterone (11-KT), may open a separate path of measurement, which may be more potent. The study was conducted with the objectives to analyze the association of 11-KT and DHT with established markers and with the clinical profile of PCOS patients. Materials and Methods: A case–control study was conducted on 30 newly diagnosed cases of PCOS as per the Rotterdam criteria and 30 age-matched controls. The estimation of testosterone, DHEAS, 11-KT, and DHT was performed by the enzyme-linked immunoassay (ELISA) method. The assessment of biochemical and hormonal parameters was compared and correlated with 11-KT and DHT.
Results
Compared to the controls, cases had significantly higher 11-KT (20.81 ± 3.53 vs. 15.83 ± 2.67 nmol/L, P < 0.0001) and DHT (154.39 vs. 71.02 pg/mL, P < 0.0001). 11-KT showed a significant positive correlation with total testosterone (TT) (r = 0.555) and DHEAS (r = 0.501). DHT also showed a significant positive correlation with TT (r = 0.487) and DHEAS (r = 0.52).
Conclusion
In conclusion, novel androgen derivatives (11-KT and DHT) hold equivalent evidence for the evaluation of women with PCOS as they are raised in women with PCOS as compared to controls. Moreover, they show a good correlation with the standard markers currently used for PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, ABVIMS and Dr. RML Hospital, New Delhi, India.
- Department of Obstetrics and Gynaecology, ABVIMS and Dr. RML Hospital, New Delhi, India.
Zitieren
APA
Kumar, N., Sharma, N., Roy, S., Chawla, I., & Sharma, L. K. (2025). A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS). Advanced Biomedical Research, 14(1). https://doi.org/10.4103/abr.abr_262_23
Vancouver
Kumar N, Sharma N, Roy S, Chawla I, Sharma LK. A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS). Advanced Biomedical Research. 2025;14(1). doi:10.4103/abr.abr_262_23
BibTeX
@article{Kumar2025,
author = {Kumar, Nirmal and Sharma, Neera and Roy, Smita and Chawla, Indu and Sharma, Lokesh Kumar},
title = {A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS)},
journal = {Advanced Biomedical Research},
year = {2025},
volume = {14},
number = {1},
doi = {10.4103/abr.abr_262_23}
}
EUVIMED